Julie Crljen

About Julie Crljen

Julie joined Medicine by Design in February 2020. She previously worked for more than a decade with one of Canada’s largest health charities, gaining experience in fundraising, branding, marketing and implementing organizational communications strategy across large teams. She has an honors BA in cultural studies from York University and a post-graduate bachelors degree in journalism from the University of King’s College, as well as a certificate in editing from Simon Fraser University and a graduate certificate in creative writing from Humber College.

DTPX Therapeutics and Azane Therapeutics are the top teams at the Building a Biotech Venture Pitch Competition

Research grants awarded to products that could impact cancer and rare genetic diseases.

Several Medicine by Design-funded projects to be further advanced by Stem Cell Network investment

The Medicine by Design-funded researchers awarded come from disciplines that include stem cell biology, neuroscience and biomedical engineering.

By |2022-05-13T09:21:39-04:00May 12th, 2022|Categories: News|Tags: , , , |

New Medicine by Design-funded research shows lab-made endothelial cells may be able treat liver diseases including hemophilia A

New research is a step forward to cell therapies for liver disease

By |2022-04-20T12:26:08-04:00April 12th, 2022|Categories: News, Research Publication|Tags: , , , |

Two multi-disciplinary research teams awarded Catalyst Grants co-sponsored by Medicine by Design and the Data Sciences Institute

Catalyst Grants co-awarded to research projects that hold promise in strengthening the connection between data science innovation and regenerative medicine.

New Medicine by Design-supported research shows mature heart cells perform well in transplants

Study is an important step forward in researchers’ understanding of treating damaged hearts with cell therapies.

Go to Top